Academics


Department of Pharmacy Practice

The Department of Pharmacy Practice is a team of highly trained, specialized faculty with members located on each of the College's two campuses. Faculty have a broad range of expertise in areas that include infectious disease, nephrology, and endocrinology.

The department offers a well-developed, integrated Doctor of Pharmacy curriculum complemented by a robust pharmacy skills course and problem solving workshops across the P1 through P3 years. Curricular concentrations are available in Nephrology and Administration/Management/Economics (AME).

The Department has more than 600 pharmacy practice sites for students to complete their rotation requirements, including two student operated pharmacies – one in Albany, NY and another in Schenectady, NY.

In addition, the Department offers several unique post-graduate training programs: (1) an endocrinology residency which is the only one of its kind in the country; (2) a nephrology residency which is one of only two such programs in the country; (3) a residency in medication management through a partnership with Clinical Support Services; and (4) a fellowship in specialty compounding in conjunction with Custom Medicine Pharmacenter.

Departmental Faculty

 

2016 Scholarly activity report

The activities listed below are by members of the Department of Pharmacy Practice and span the period from January 1, 2016 - December 31, 2016.

publications

Monique Bidell
Bidell MR, McLaughlin M, Faragon J, Morse C, Patel N. Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need. Infectious Diseases and Therapy 2016 Jul 6 (ePub ahead of print).

Lodise TP, Bidell MR, Flanagan SD, Zasowski EJ, Minassian SL, Prokocimer P. Characterization of the haematological profile of 21 days of tedizolid in healthy subjects. Journal of Antimicrobial Chemotherapy 2016 Jun 17 (ePub ahead of print).

Bidell MR, Lodise TP. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk? Pharmacotherapy 2016 May 3 (ePub ahead of print).

Bidell MR, Palchak M, Mohr J, Lodise TP. Fluoroquinolone and Third-Generation Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region? Antimicrobial Agents and Chemotherapy 2016 Apr 22;60(5):3170-3.

Katie Cardone
Parker WM, Ferreira K, Vernon L, Cardone KE. The delicate balance of keeping it all together: Using social capital to manage multiple medications for patients on dialysis. Research in Social and Administrative Pharmacy, 2016 Aug 3 (ePub ahead of print).

Davis JM, Wegrzyn N, Cardone KE. Sweetening the deal: Effects of SGLT-2 inhibitors in kidney disease progression. iForumRx, November 2016.

Jo Carreno
Carreno JJ, Kenney RM, Divine G, Vazquez JA, Davis SL. Randomized Controlled Trial to Determine the Efficacy of Early Switch From Vancomycin to Vancomycin Alternatives as a Strategy to Prevent Nephrotoxicity in Patients With Multiple Risk Factors for Adverse Renal Outcomes (STOP-NT). Annals of Pharmacotherapy, 2016 Nov 11.

Carreno JJ, Lomaestro B, Jacobs AM, Meyers RM, Evans A, Montero C. Assessment of Time to Clinical Response in Patients with Sepsis Treated Before and After a Implementation of a Matrix-Assisted Laser Desorption Ionization Time of Flight Based Blood Culture Identification Algorithm. Infection Control & Hospital Epidemiology, 2016 Aug;37(8):916-23. doi: 10.1017/ice.2016.105.

Jacqueline Cleary
Cleary J, Nicewicz K, Fudin J. Life-Saving Naloxone: Review of Currently Approved Products. Practical Pain Management, 2016 September 16(7).

Atkinson TJ, Pratt Cleary J, Fudin J. 10 Pain Medication Myths: Challenges in Selecting the Appropriate Analgesic. Practical Pain Management, 2016 July/August 16(6): 63-70.

Thomas Lodise
Rahbar AJ, Lodise TP, Abraham P, Lockwood A, Pai MP, Patka J, Rabinovich M, Curzio K, Chester K, Williams B, Morse B, Chaar M, Huang V, Salomone J. Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients with Sepsis. Surgical Infections (Larchmt), 2016 Dec;17(6):675-682.

Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH. Evaluation of Vancomycin Exposures Associated with Elevations in Novel Urinary Biomarkers of Acute Kidney Injury in Vancomycin-Treated Rats. Antimicrobial Agents and Chemotherapy, 2016 Sep 23;60(10):5742-51.

Lodise TP, Bidell MR, Flanagan SD, Zasowski EJ, Minassian SL, Prokocimer P. Characterization of the haematological profile of 21 days of tedizolid in healthy subjects. Journal of Antimicrobial Chemotherapy, 2016 Sep;71(9):2553-8.

Jensen IS, Wu E, Fan W, Lodise TP, Nicolau DP, Dufour S, Cyr PL, Sulham KA. Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis. Journal of Managed Care & Specialty Pharmacy, 2016 Jun;22(6):752-64. doi: 10.18553/jmcp.2016.22.6.752.

Bidell MR, Palchak M, Mohr J, Lodise TP. Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region? Antimicrobial Agents and Chemotherapy, 2016 Apr 22;60(5):3170-3.

Jensen IS, Lodise TP, Fan W, Wu C, Cyr PL, Nicolau DP, DuFour S, Sulham KA. Use of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact Analysis. Clinical Drug Investigation, 2016 Feb;36(2):157-68.

Lodise TP, Fan W, Sulham KA. Economic Impact of Oritavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in the Emergency Department or Observation Setting: Cost Savings Associated with Avoidable Hospitalizations. Clinical Therapeutics, 2016 Jan 1;38(1):136-48.

Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, Bauer K, Goff DA, Adamson R, Leuthner K, Virata MD, McKinnell JA, Chaudhry SB, Eskandarian R, Lodise T, Reyes K, Zervos MJ. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation. Clinical Therapeutics, 2016 Jan 1;38(1):16-30.

Bidell MR, Lodise TP. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk? Pharmacotherapy, 2016 Jun;36(6):679-93.

Martirosov DM, Lodise TP. Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae. Diagnostic Microbiology and Infectious Diseases, 2016 Jun;85(2):266-75.

J. Nicholas O’Donnell
Rhodes NJ, Prozialeck WC, Lodise TP, Venkatesan N, O'Donnell JN, Pais G, Cluff C, Lamar PC, Neely MN, Gulati A, Scheetz MH. Evaluation of vancomycin exposures associated with elevations in novel urinary biomarkers of acute kidney injury in vancomycin-treated rats. Antimicrobial Agents and Chemotherapy 2016; 60: 5742-5751.

Whited L, Grove M, Rose D, Rhodes NJ, Scheetz MH, O'Donnell JN, Neeb J, Thoele K, Jones DR, Lowe C, Moore D, Kiel PJ. Pharmacokinetics of cefepime in patients with cancer and febrile neutropenia in the setting of hematologic malignancies or hematopoietic cell transplantation. Pharmacotherapy 2016; 36: 1003-1010.

O’Donnell JN, O’Donnell EP, Gulati A, Lavhale MS, Kumar EJ, Scheetz MH. Centhaquin citrate pharmacokinetics in a dog model. Journal of Pharmacy and Pharmacology 2016; 68: 803-809.

Scheetz MH, Crew PE, Miglis C, Gilbert EM, Sutton SH, O’Donnell JN, Postelnick M, Zembower T, Rhodes NJ. Investigating the extremes of antibiotic use with an epidemiologic framework. Antimicrobial Agents and Chemotherapy 2016; 60: 3265-3269.

O’Donnell JN, Miglis CM, Lee JY, Tuvell M, Lertharakul T, Scheetz MH. Carbapenem susceptibility breakpoints, clinical implications with the moving target. Expert Review of Anti-infective Therapy; 14: 389-401.

O’Donnell JN, Venkatesan N, Manek M, Rhodes NJ, Scheetz MH. Visual and absorbance analyses of vancomycin and piperacillin-tazobactam incompatibilities at a range of commonly utilized doses. American Journal of Health-System Pharmacy 2016; 73: 241-246.

Rhodes NJ, O’Donnell JN, Lizza BD, Mclaughlin MM, Esterly JS, Scheetz MH. Tree based models for the prediction of mortality in Gram negative bacteremia: avoid putting the CART before the horse. Antimicrobial Agents and Chemotherapy 2016; 60: 838-844.

O’Donnell JN, Gulati A, Lavhale MS, Sharma SS, Patel AJ, Rhodes NJ, Scheetz MH. Pharmacokinetics of centhaquin citrate in a rat model. Journal of Pharmacy and Pharmacology 2016; 68: 56-62.

Nimish Patel
Bidell MR, McLaughlin M, Faragon J, Morse C, Patel N. Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need. Infectious Diseases and Therapy, 2016 Sep;5(3):299-312. doi: 10.1007/s40121-016-0118-x. Epub 2016 Jul 6. Review.

Britt NS, Potter EM, Patel N, Steed ME. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Clinical Infectious Diseases 2016 Dec 22. pii: ciw815. doi: 10.1093/cid/ciw815 (ePub ahead of print).

Britt NS, Patel N, Shireman TI, El Atrouni WI, Horvat RT, Steed ME. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy 2016 Dec 20. pii: dkw453. doi: 10.1093/jac/dkw453 (ePub ahead of print).

Britt NS, Patel N, Horvat RT, Steed ME. Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrobial Agents and Chemotherapy 2016 Apr 22;60(5):3070-5. doi: 10.1128/AAC.02714-15, May 2016.

Joanna Schwartz
Moukharskaya J, Abrams DM, Khan FB, Schwartz J, Ades S, Ashikaga T. Randomized Phase 2 Study of Loratadine for the prevention of bone pain cause by pegfilgrastim. Supportive Care Cancer, July 2016; 24(7): 3085-3093.

Kimberly Skylstad
Garren T, Skylstad KA. Scaffolded Online Learning Modules for Milliequivalency and Milliosmolarity. Currents in Pharmacy Teaching and Learning 2016;8:316-322.

Aimee Strang
Baia P, Strang AF. Pharmacy Educator Motives to Pursue Pedagogical Knowledge. American Journal of Pharmaceutical Education, 2016; 80(8): 132.

Strang AF, Baia P. An Investigation of Teaching and Learning Programs in Pharmacy Education. American Journal of Pharmaceutical Education, 2016; 80(4):59.

Lamba S, Strang A, Edelman D, Navedo D, Soto-Greene ML, Guarino AJ. Promoting interprofessionalism: initial evaluation of a master of science in health professions education degree program. Advances in Medical Education and Practice, 2016; 7: 51–5.

Matthew Stryker
Stryker M, Kane M, Busch R. Lack of Cross-Reactivity Following a Switch from Alirocumab to Evolocumab. Excerpts in Pharmacy Research Journal 2016;2:1-2.

Stryker M, Kane M, Busch R. A Pharmacist-Run Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Clinic: Short-Tem Results and Practical Strategies. Pharmacotherapy 2016;36(7)e83-e138.

Stryker M, Kane M, Busch R. An Evaluation of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Patients with Diabetes Mellitus. Journal of Clinical Lipidology, 10(3):720, May 2016.

Michael Kane
Stryker MD, Kane MP, Busch RS. Lack of Cross-Reactivity Allergy Following a Switch from Alirocumab to Evolocumab. Excerpts in Pharmacy Research Journal, 2016;2:1-3.

Stryker MD, Kane MP, Busch RS. An Evaluation Of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors In Patients With Diabetes Mellitus. Journal of Clinical Lipidology, 10(3):720, May 2016.

Saroka RM, Kane MP, Robinson L, Busch RS. No postoperative adrenal insufficiency in a patient with unilateral cortisol-secreting adenomas treated with mifepristone before surgery. Clinical Med Insights: Endocrinology and Diabetes, 2016;9:31-6.

Kane MP, Hamilton RA. Determination of the glycemic index of a diabetes truffle. Journal of Global Diabetes and Clinical Metabolism, 2016;1:22-4.

Brady SM, Kane MP, Busch RS. GLP-1 Agonist Use in a Patient with an Explainable Cause of Pancreatitis. AACE Clinical Case Reports, Spring, 2016. DOI 10.4158/EP15658.CR.

Jacqueline Cleary
Fudin J, Pratt Cleary J, Sparkes S. “Opioid Analgesics” in Pain Management Secrets, Fourth ED. Dubin, Andrew, et al, Elsevier Health Sciences, 2016 (publication pending).

Jessica Farrell
Farrell JF, Kennedy AG. “Psoriatic Arthritis” in Ambulatory Care Self-Assessment Program (ACSAP), 2016 Book 1, Endocrinologic/Rheumatologic Care. Dong BJ, Elliott DP, eds. Lenexa, KS: American College of Clinical Pharmacy, 2016.

Michael Kane
Jonklaas J, Kane MP. “Thyroid disorders” in Pharmacotherapy: A Pathophysiologic Approach, 10th edition. DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. New York, NY: McGraw-Hill Education, 2016.

Kane MP. “Endocrine Disorders” in Updates in Therapeutics: Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2016 ed. Bainbridge JL, Cardone K, Cross LB, et al. Lenexa, KS: American College of Clinical Pharmacy, 2016:1-679 - 1-740.

Katie Cardone
Wegrzyn NM, Cardone KE. “Are intravenous iron sucrose products interchangeable? Efficacy and safety of original and generic formulations in hemodialysis patients.” Textbook Update, AccessPharmacy Web site, New York: McGraw-Hill, September 2016.

Cardone KE. “End-Stage Kidney Disease” in Pharmacotherapy Casebook: A Patient-Focused Approach, 10th ed. Schwinghammer TL, Koehler JM, eds., McGraw-Hill, 2016.
Cardone KE. “Nephrology” in Review and Recertification Book for Board Certification in Ambulatory Care Pharmacy. American College of Clinical Pharmacy, 2016.

POSTER/PLATFORM PRESENTATIONS

Monique Bidell
Fimansyah A, Nguyen H, Bidell M, Han Z, Pettit NN. Outcomes associated with time-to-antibiotic administration among patients with febrile neutropenia in the emergency department. ASHP Midyear Exhibition, Las Vegas, NV, December 2016.

Brown SJ, Lane SM, Bidell MR. Assessment of institutional fluoroquinolone use for uncomplicated infections. ASHP Midyear Exhibition, Las Vegas, NV, December 2016.

Falli E, Poucher A, Lombardi CL, Ferri D, Bidell MR. Evaluation of an adjusted body weight-based vancomycin dosing guideline. ASHP Midyear Exhibition, Las Vegas, NV, December 2016.

Bidell MR, Lodise TP. Levofloxacin-associated tendinopathy: What is the risk? ACPHS Research Forum, Albany, NY, January 2016; Making A Difference in Infectious Diseases (MAD-ID), Orlando, FL, May 2016.

Laurie Briceland
Rosa S, Briceland L. Introducing students to Pharmacy Ownership through the development of an Entrepreneurial APPE Rotation. 2016 AACP Annual Meeting (abstract).

Briceland L, Rosa S, Lubowski T, Jablanski C. Creation of Experiential Education Honors Policies to Recognize Exemplary IPPE and APPE Performance. AACP Annual Meeting, Anaheim, CA, July 25, 2016 (abstract).

Katie Cardone
Cardone KE, Daoui S, Daoui R, Donato KM, Parker WM. Factors Affecting Medication Management among Patients with Chronic Kidney Disease (abstract SA-PO924). American Society of Nephrology 2016 Kidney Week, Chicago, IL, November 2016. Journal of the American Society of Nephrology 27:2016.

Cardone KE, Zheng H, Balk N, Rivenburg K, DiCenzo R. Promoting Pharmacy through Recruitment for Two Campuses in Two States. American Association of Colleges of Pharmacy Annual Meeting, Anaheim, CA, July 23-27, 2016.  

Parker WM, Wegrzyn NM, Pai AB, Daoui R, Daoui S, Cardone KE. Health Literacy and Self-Management of Medications among Patients at an Outpatient Nephrology Office. AcademyHealth Annual Research Meeting, Boston, MA, June 27, 2016.

Wegrzyn NM, Parker WM, Pai AB, Daoui R, Daoui S, Cardone KE. Assessing health literacy in outpatient nephrology patients. National Kidney Foundation Spring Clinical Meeting, Boston, MA, April 2016.

Brian Cowles
Lipinksi H, Cowles B, Young L. Dobutamine-induced rash in a critically ill full-term neonate: A case report. ASHP Midyear Clinical Meeting, Las Vegas, NV, December 6, 2016.

Jessica Farrell
Farrell JF. Pharmacist-Developed Letters Used to Obtained Inclusion of Off-Label Indications of Rheumatic Drugs within National Compendia. Scleroderma Foundation National Patient Education Conference, New Orleans, LA, July 2016.

Loy T, Farrell JF, Bruce SP. Pharmacist- and student-developed letters to national compendia to acquire off-label status. ASHP Midyear Clinical Meeting & Exhibition, Las Vegas, NV, December 2016.

Gina Garrison
Quidort A, Wales D, Garrison GD, Lindstrom J, Verrico I. Improving Immunization Rates of Children Age 19 to 35 months: An Interprofessional Approach at a Multidisciplinary Training Site. American Academy of Pediatrics (AAP) National Conference & Exhibition, San Francisco, CA, October 22-25, 2016.

Michael Kane
Stryker M, Kane M, Busch R, Hamilton R. An Evaluation of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Patients with Diabetes Mellitus (abstract 187). National Lipid Association’s Scientific Sessions, New Orleans, LA, May 18, 2016.

Stryker M, Kane M, Busch R, Hamilton R. A Pharmacist-Run Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Clinic: Short-Term Results and Practical Strategies (poster 97). American College of Clinical Pharmacy’s Virtual Poster Symposium, May 18, 2016.

Bizier J, Kane MP, Busch RS, Bakst G, ElDeiry SE, Hamilton RA. Efficacy and Safety of Switching Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor Therapy in Type 2 Diabetes Mellitus. ASHP Midyear Clinical Meeting, Las Vegas, NV, December 7, 2016.

Nicole Lodise
Bartelme KM, Lodise NM, Rafie S, Shealy K, Stone R, Vernon V. The Women’s Health PRN Members and Accomplishments. American College of Clinical Pharmacy (ACCP) Annual Meeting, Hollywood, FL, October 2016.

Thomas Lodise
Lodise TP, Ye M, Keyloun KR, Zhao Q, Gillard P. Identification of Patients at Greatest Risk for Carbapenem Resistance in Patients With Serious Hospital-Onset Infections Due to Enterobacteriaceae Species (abstract 1794). Oral Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Lodise.

Berger A, Bhagnani T, Wang R, Zhao Q, Ye M, Lodise TP. Does Timing of Receipt of Appropriate Antimicrobial Therapy Make a Difference Among Patients with Serious Infections due to Resistant Gram-negative Pathogens? (abstract 1796). Oral Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Lodise.

Luther M, Caffrey A, Dosa D, Lodise TP, LaPlante K. Vancomycin plus Piperacillin/Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-analysis (abstract 1805). Poster Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Luther.

Lodise TP. Wang R, Bhagnani T, Zhao Q, Ye M, Berger A. Clinical and Economic Burden of Multi-drug Resistant Pseudomonas sp. (MDRP) Among Patients with Serious Infections in US Hospitals (abstract 2045). Poster Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Lodise.

Mckinnell JA, Corman S, Patel D, Lodise TP. Telavancin vs. Vancomycin in the Treatment of Hospital-Acquired Pneumonia Caused by S. Aureus: Decision Analytic Model (abstract 1250). Poster Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Mckinnell JA.

Martin A, Fahrbach K, Zhao Q, Lodise T. Association between Carbapenem Resistance and Mortality among Adults Hospitalized with Serious Infections due to an Enterobacteriaceae spp: Results of a Systematic Literature Review and Meta-Analysis (abstract 355). Poster Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Martin.

Natesan S, Pai MP, Lodise TP. Determination of Alternative Ceftolozane/Tazobactam (C/T) Dosing Regimens for Patients with Infections Due to Pseudomonas aeruginosa with high (C/T) MIC values (abstract 1959). Poster Presentation at IDWeek2016, New Orleans, LA, October 26-30, 2016. Presenter: Natesan.

Huang D, Lodise T. Use of PK/PD Systems Analyses to Determine the Optimal Fixed Dosing Regimen of Iclaprim (ICL) for Phase III ABSSSI Clinical Trial. Abstract 1971. Poster Presentation at IDWeek2016™: A Joint Meeting of IDSA, SHEA, HIVMA, and PIDS. New Orleans, LA, October 26-30, 2016. Presenter: Huang.

Carreno JJ, Lomaestro BM, Tietjan J, Lodise T. Validation Of A Bayesian Approach To Estimate Vancomycin Exposure In Obese Patients With Limited PK Sampling (abstract 496). Poster Presentation at ASM Microbe 2016, Boston, MA, June 16-20, 2016. Presenter: Carreno.

O'Donnell J, Rhodes NJ, Lodise T, Prozialeck W, Miglis CH, Natarajan V, Joshi M, Pais G, Lamar P, Cluff C, Gulati A, Scheetz MH. 24-Hour Pharmacokinetic Relationships for Vancomycin (Van) and Novel Urinary Biomarkers of Acute Kidney Injury (abstract 517). Poster Presentation at ASM Microbe 2016, Boston, MA, June 16-20, 2016. Presenter: O'Donnell.

Schriever C, Ahmed A, Delehanty KR, Yager J, Farrow G, Kashtan R, Lodise T, Patel N. Comparison of frequencies of drug-drug interactions between sofosbuvir/ledipasvir and ombitasvir/dasabuvir/paritaprevir/ritonavir +/- ribavirin among HIV/HCV coinfected patients (abstract SAT-223). Poster presentation at the European Association for the Study of the Liver – International Liver Congress, Barcelona, ES, April 2016. Presenter: Patel.

Yager J, Lodise T, Patel N. Minimum adherence threshold necessary to achieve virologic suppression (abstract 1995). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Patel N, Yager J, McGuey L, Hoye-Simek A, Lodise T. Relationship between single-tablet regimen and adherence to HIV and non-HIV medications (abstract 1998). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Patel N, Hecox Z, Morse C, Sullivan S, Hoye-Simek A, Yager J, Lodise T. Maintenance of non-HIV cardiometabolic comorbidity control among HIV-infected veterans’ affairs patients: a comparison between single tablet and multiple tablet antiretroviral regimens (abstract 1991). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Yager J, Lodise T, Patel N. Minimum adherence threshold needed for maintenance of virologic suppression (abstract 1993). Platform presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Yager.

J. Nicholas O’Donnell
O’Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Miglis CM, Venkatesan N, Joshi M, Pais G, Lamar PC, Cluff C, Gulati A, Scheetz MH. 24-hour pharmacokinetic relationships for vancomycin and novel urinary biomarkers of AKI. 1st American Society of Microbiology Microbe, Boston, MA, June 2016.

Nimish Patel
Yager J, Lodise T, Patel N. Minimum adherence threshold needed for maintenance of virologic suppression (abstract 1993). Platform presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Yager.

Patel N, Hecox Z, Morse C, Sullivan S, Hoye-Simek A, Yager J, Lodise T. Maintenance of non-HIV cardiometabolic comorbidity control among HIV-infected veterans’ affairs patients: a comparison between single tablet and multiple tablet antiretroviral regimens (abstract 1991). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Patel N, Yager J, McGuey L, Hoye-Simek A, Lodise T. Relationship between single-tablet regimen and adherence to HIV and non-HIV medications (abstract 1998). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Yager J, Lodise T, Patel N. Minimum adherence threshold necessary to achieve virologic suppression (abstract 1995). Poster presentation at the 26th European Congress on Clinical Microbiology and Infectious Diseases, Amsterdam, NL, April 2016. Presenter: Patel.

Schriever C, Ahmed A, Delehanty KR, Yager J, Farrow G, Kashtan R, Lodise T, Patel N. Comparison of frequencies of drug-drug interactions between sofosbuvir/ledipasvir and ombitasvir/dasabuvir/paritaprevir/ritonavir +/- ribavirin among HIV/HCV coinfected patients (abstract SAT-223). Poster presentation at the European Association for the Study of the Liver – International Liver Congress, Barcelona, ES, April 2016. Presenter: Patel.

Britt NS, Potter EM, Patel N, Steed ME. Derivation And Validation Of A Mortality Risk Assessment Model For Vancomycin-Resistant Enterococcal (Vre) Bacteremia Based On Source Of Infection (session 333). Platform presentation at American Society for Microbiology Microbe Meeting, Boston, MA, June 2016. Presenter: Britt.

Britt NS, Potter EM, Patel N, Steed ME. Clinical Outcomes In Vancomycin-Resistant Enterococcus (VRE)/Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Coinfection Treated With Daptomycin Or Linezolid (abstract 396). Poster presentation at American Society for Microbiology Microbe Meeting, Boston, MA, June 2016. Presenter: Britt.

Ahmed AA, Schriever C, Amin R, Delehanty KR, Yager J, Patel N. Comparing the Population-Based Frequency of Contraindicated Drug-Drug Interactions between Daclatasvir/Sofosbuvir (DAC/SOF), Grazoprevir/Elbasvir (GZR/EBV), Ledipasvir/Sofosbuvir (LDV/SOF), Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir ± Ribavirin (OMB/PTV/RTV + DSV ± RBV) and Simeprevir/Sofosbuvir (SIM/SOF) for Treatment of Hepatitis C Monoinfection (abstract 60260). Poster presentation at IDWeek 2016. New Orleans, LA, October 2016. Presenter: Patel.

Yager J, Faragon J, Patel N. Quantifying the minimum adherence threshold associated with the development of reverse transcriptase mutations among HIV-infected Veterans’ Affairs patients receiving antiretroviral therapy (abstract 225954). Poster Presentation at the 2016 ASHP Midyear Clinical Meeting, Las Vegas, NV, December 2016. Presenter: Yager.

Sangiovanni RJ, Yager J, Donadio A, Farrow G, Patel N. Use of vancomycin in VISN-2 patients who have previously experienced vancomycin-associated acute kidney injury (AKI): Predictors and outcomes of secondary vancomycin-associated AKI (abstract 225960). Poster presentation at the 51st ASHP Midyear Clinical Meeting and Exhibition, Las Vegas, NV, December 2016. Presenter: Sangiovanni.

Lee Anna Obos
Obos L. Two Phase Pharmacy Skills Laboratory Video Project: Student Reactions and Effect on Lab Performance, AACP Annual Meeting, Anaheim, CA, July 2016.  

Sandra Rosa
Rosa S, Briceland L. Introducing students to Pharmacy Ownership through the development of an Entrepreneurial APPE Rotation. 2016 AACP Annual Meeting (abstract).

Briceland L, Rosa S, Lubowski T, Jablanski C. Creation of Experiential Education Honors Policies to Recognize Exemplary IPPE and APPE Performance. AACP Annual Meeting, Anaheim, CA, July 25, 2016 (abstract).

Matthew Stryker
Stryker M, Kane M, Busch R, Hamilton R. An Evaluation of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in Patients with Diabetes Mellitus. 2016 National Lipid Association’s Scientific Sessions, Abstract Identification: 187.

Stryker M, Kane M, Busch R, Hamilton R. A Pharmacist-Run Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Clinic: Short-Term Results and Practical Strategies. American College of Clinical Pharmacy’s 2016 Virtual Poster Symposium, Poster Number: 97.

INVITED PRESENTATIONS

Kelly Bach
Bach K. Delivering a powerful residency interview presentation. ACPHS/NYSCHP Residency Preparation Symposium, ACPHS, Albany, NY, October 2016.

Monique Bidell
Bidell M. A case of vomiting, malaise and acute injury (co-presented with Yolana Fuks and David Colman). Medical Grand Rounds, St. Peter’s Hospital, Albany, NY, December 2016.

Bidell M. Fluoroquinolone safety: Tipping the risk-benefit scale. PharmaMed 2016, Dubai, United Arab Emirates, December 2016.

Bidell M. Why complete a pharmacy residency and how to prepare to be a competitive candidate (co-presented with Kate Cabral). ACPHS/NYSCHP Residency Preparation Symposium, ACPHS, Albany, NY, October 2016.

Bidell M. Updates in antimicrobial safety: Focus on fluoroquinolones. Continuing Education. Infectious Diseases Symposium, ACPHS, Albany, NY, February 2016.

Abby Boire
Boire A. Updates in Heart Failure Therapy: What the Pharmacist Needs to Know. April 2016.

Jeffrey Brewer
Brewer JM. Professional Organizations Council: AACP Interim Meeting Report, Effective Leadership, Spring 2016.

Laurie Briceland
Briceland L. Overview of Antimicrobial Therapy. Sage College Nurse Practitioner Program, February 2016.

Michael Brodeur
Brodeur MR. FOAM – Free Open Access Medical education – Medical education for anyone, anywhere, anytime. American Society of Consultant Pharmacist Annual Meeting, Dallas, TX, November 4, 2016.

Brodeur MR. Colonie Emergency Medical Services. Continuing Education. November 2016.

Brodeur MR. Falls and Their Prevention: A Geriatrics and Pharmacological Imperative Fall Risk Identification and Intervention for the Community-Dwelling Older Adult. Public Health Live,
SUNY School of Public Health, October 20, 2016.

Brodeur MR. Pill Pruning - The Art and Science of Deprescribing. Office of Postgraduate Education, ACPHS, June 8, 2016.

Brodeur MR. Pain Management in an Era of Uncertainty. Pharmacist Society of
the State of New York (PSSNY), Mid-Winter Meeting, Saratoga, NY, January 30, 2016.

Katherine Cabral
Why Complete a Pharmacy Residency? NYSCHP/ACPHS Residency Prep Symposium, Albany College of Pharmacy and Health Sciences, Albany NY, October 2016.

Through Thick & Thin: An Update on Anticoagulants. Continuing Education. ACPHS Cardiovascular Symposium, Albany College of Pharmacy and Health Sciences, Albany, NY, April 2016.

Katie Cardone
Cardone K. Updates In Type 2 Diabetes Management: Guideline Updates. Continuing Education (co-presented with See-Won Seo). Mohawk Valley Pharmacists Association, Utica, NY, December 2016.

Cardone K. Use of SGLT2 Inhibitors in Treating T2D. Continuing Education. Mohawk Valley Pharmacists Association, Utica, NY, December 2016.

Cardone K. Updates In Type 2 Diabetes Management: Case-Based Discussion Of Diabetes Management. Continuing Education (co-presented with See-Won Seo). Mohawk Valley Pharmacists Association, Utica, NY, December 2016.

Cardone K. Pharmacology, Pharmacokinetics and Pharmacodynamics in Diabetic Kidney Disease: Give It Your Best Shot: Newer Diabetes Agents in CKD. Continuing Education. American Society of Nephrology Kidney Week, Chicago, IL, November 2016.

Cardone K. Newer Agents and Their Implications for Patients with Chronic Kidney Disease: The Current and Potential Role of SGLT-2 Inhibitors in Patients with Chronic Kidney Disease. Continuing Education. Annual Meeting of the American College of Clinical Pharmacy, Hollywood, FL, October 25, 2016.

Cardone K. Delivering Medication Therapy Management in the Community. Continuing Education and Certificate Training Program. Mohawk Valley Pharmacists Association, Utica, NY, Spring 2016.

Cardone K. Update on Diabetic Kidney Disease (DKD) Management: SGLT-2 inhibitors. Continuing Education. National Kidney Foundation Spring Clinical Meeting, Boston MA, May 2016.

Cardone K. Anemia Workshop: Management of ESA Hyporesponse: A Fine Balance. Continuing Education. National Kidney Foundation Spring Clinical Meeting, Boston, MA, May 2016.

Cardone K. Pragmatic Drug Dosing across the Continuum in Kidney Disease: Drug Dosing In Hemodialysis – Time Over Matter? Continuing Education and Active Learning Case Session. National Kidney Foundation Spring Clinical Meeting, Boston, MA, May 2016 (session chair/moderator).

Cardone K. Pragmatic Drug Dosing across the Continuum In Kidney Disease: Drug Dosing In Peritoneal Dialysis. Continuing Education and Active Learning Case Session. National Kidney Foundation Spring Clinical Meeting, Boston, MA, May 2016 (session chair/moderator).

Cardone K. Nephrology Review for the Ambulatory Care Pharmacist Review and recertification course for board certified ambulatory care pharmacists (BCACP). American College of Clinical Pharmacy Spring Conference, Phoenix, AZ, April 2016.

Jo Carreno
Carreno J. Zika Virus: Beyond the Hype. Continuing Education. Capital Area Pharmacists Society, Albany, NY.

Carreno J. The Use of Rapid Diagnostics within Antimicrobial Stewardship Programs. Continuing Education. ACPHS, Albany, NY.

Jacqueline Cleary
Cleary J. Opioid Induced Respiratory Depression and In-Home Naloxone Use: Application of the Risk Index for Overdose or Serious Opioid Induced Respiratory Depression (RIOSORD) Tool. Continuing Education. Alden March Bioethics Institute Clinical Ethics Conference, ACPHS, Albany, NY, November 19, 2016.

Cleary J. Pharmacist’s Role in Naloxone Education and Distribution. Rho Chi and PLS joint meeting, ACPHS, Albany, NY, November 2016.

Cleary J. Opioid Induced Respiratory Depression and Naloxone Distribution: Application of the RIOSORD Tool. Continuing Education. Annual Preceptor Training Day, ACPHS, Albany, NY, August 2016.

Giselle D’Epiro
D’Epiro G. Vitamin Supplementation in Women. University of Vermont Women’s Health Conference, 2016.

D’Epiro G. The New Anticoagulants. UVM Family Medicine Review Course, 2016.

Jessica Farrell
Farrell JF. Proton Pump Inhibitors (PPI): How to Digest the News? Scleroderma Foundation National Patient Education Conference, New Orleans, LA, July 29, 2016.

Farrell JF. The Role of Biologics in Psoriatic Arthritis. Continuing Education. ACPHS, Albany, NY, September 2016.

Gina Garrison
Garrison G. 2016 Annual CDC Immunization Updates for Adult and Infants / Children / Adolescents. AMC Internal Medicine and Pediatrics Group, Latham, NY.

Garrison G. 2016 Updates in Pharmacotherapy for Adult Dyslipidemia. Continuing Education. Albany Medical College – Internal Medicine and Pediatric Update, Saratoga, NY.

Garrison G. 2016 Updates in Pharmacotherapy for Adult Dyslipidemia. Continuing Education. ACPHS Cardiovascular Update, Albany, NY.

Garrison G. Dyslipidemia: Would every woman should know. Capital Region Women’s Business Council, Albany, NY.

Elizabeth Higdon
Higdon E. Calamine Compounding Workshop. Presented to high school students at TRIO event, Colchester, VT, February 2016.

Michael Kane
Kane M. Diabetes Update. American Society of Consulting Pharmacists Mid-State New York Chapter Meeting and Education Day, Syracuse, NY, June 16, 2016.

Kane M. Keynote Address. The Capital District Residency & Fellowship Graduation Luncheon, Albany, NY, June 8, 2016.

Kane M. Strategies for Diabetes Prevention. Mid-Hudson Regional Hospital Pre-diabetes Epidemic Conference: Public Health Impact & Prevention of Type 2 Diabetes, Poughkeepsie, NY, May 14, 2016.

Kane M. Endocrine Disorders. For Ambulatory Care Pharmacy Preparatory Review Course, ACCP 2016 Updates In Therapeutics, Phoenix, AZ, April 9, 2016.

Kane M. The New Classes of Diabetes Medications: A Synopsis. Grand Rounds at the Baystate Medical Center, Springfield, MA, March 22, 2016.

Kane M. Obesity Is a Chronic Disease: Let’s Treat it That Way. APhA Annual Meeting, Baltimore, MD, March 7, 2016.

Teresa Kane
Kane T. Aseptic Technique Training Videos. ACPHS Instructional Design Symposium, Spring 2016.

David Kile
Kile D. Profiles in Leadership Hollywood Version Instructional Design Symposium. ACPHS, March 23, 2016.

Kile D. Medication Adherence: America’s Other Drug Problem. ACPHS Pharmacy Practice Update, June 8, 2016.

Nicole Lodise
Lodise NM. JCPP Pharmacist’s Patient Care Process: Standardizing the Approach to Patient Care. Continuing Education. Albany College of Pharmacy and Health Sciences Barbara M. DiLascia Women's and Men's Health Symposium, Albany, NY, September 2016.

Lodise NM. Curricular Adoption and Integration of the Pharmacists’ Patient Care Process. American Association of Colleges of Pharmacy (AACP) Teachers’ Seminar, Anaheim, CA, July 2016.

Thomas Lodise
Vancomycin PK/PD Efficacy (symposium). “Contemporary Considerations: Cutting Edge Advances in Vancomycin Therapy.” 2016 ASHP Midyear Clinical Meeting Las Vegas, NV, December 7, 2016.

Exposure-Centric vs. Dose-Centric Drug Development Approach (workshop). “Opportunities and challenges in development of new antibacterial therapeutics.” Superbugs & Superdrugs USA 2016, Iselin, NJ, November 16, 2016.

The Drug: Update on Treatment Options (satellite symposium). “The Bug-Drug-Host Triad in the Era of Antibiotic Resistance: Focus on the Spectrum of ABSSSI.” IDWeek2016, New Orleans, LA, October 28, 2016.

Economics of Treating ABSSSI in Different Settings of Care (satellite symposium). IDWeek2016, New Orleans, LA, October 27, 2016.  

PK/PD versus frequentist approaches for drug development – Pro (debate). ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance. Vienna, Austria, September 23, 2016.  

Polymyxins, What Do We Really Know? Allergan Medical Affairs, Jersey City, NJ, June 30, 2016.

Lipoglycopeptides and Glycopeptides (symposium). “Antimicrobial Toxicodynamics (Organized in Cooperation with the International Society of Anti-Infective Pharmacology (ISAP).”
ASM Microbes 2016, Boston, MA, June 20, 2016.  

Economics of Treating ABSSI in Different Settings of Care (satellite symposium). Making a Difference (MAD) - ID Annual Meeting, Champions Gate, FL, May 6, 2016.

Quantifying Antibiotic Exposure-Effect Relationships in Patients with Infections:
A Focus on Beta-Lactams and Vancomycin. Midwestern University, Downers Grove, IL, April 15, 2016.

Advanced Pharmacokinetics/Pharmacodynamics (continuing education). New York State Council of Health-system Antimicrobial Stewardship Program, Hosted by Greater New York Hospital Association, New York, NY, March 16, 2016.

Combination Therapy for Serious Gram-Negative Infections (continuing education). New York State Council of Health-system Antimicrobial Stewardship Program, Hosted by Greater New York Hospital Association, New York, NY, March 16, 2016.

Nimish Patel
Patel N. Medication Errors in HIV. Continuing Education. Onondaga Pharmacists Society, Syracuse, NY, June 2016.

Patel N. Medication Errors in HIV. Continuing Education. Capital Area Pharmacists Society, Albany, NY, September 2016.

Patel N. Updates in Epidemiology and Treatment of Sexually Transmitted Infections. Continuing Education. ACPHS, Albany, NY, September 2016.

Patel N. Medication Errors in HIV. Continuing Education. Pharmacists’ Society of the State of New York Annual Meeting, Rye Brook, NY, June 2016.

Patel N. Medication Errors in HIV. Continuing Education. Telemedicine series broadcast to all New York State Department of Corrections pharmacists, Albany Medical Center HIV Clinic, Albany, NY, June 2016.

Patel N. Updates in Epidemiology and Treatment of Hepatitis C Infection. Continuing Education. ACPHS, Albany, NY, February 2016.

Patel N. Updates in Epidemiology and Treatment of HIV. Continuing Education. ACPHS, Albany, NY, February 2016.

Joanna Schwartz
Schwartz J. Oral chemotherapy safety and adherence. Northern New England Chapter of the American Society of Clinical Oncology (NNECOS), October 26, 2016, Bretton Woods, NH.

Schwartz J. Assessment of herbal, dietary supplement and OTC medications with chemotherapy. University of Vermont Breast Symposium, Burlington, VT, October 4, 2016.

Schwartz J. New Drug Update. Northern New England Chapter of the American Society of Clinical Oncology, October 28, 2016, Bretton Woods, NH.

See-Won Seo
Performance-Enhancing Drugs. Continuing Education. ACPHS, Albany, NY, Sept 2016.

New Drug Update. Continuing Education. Pharmacists Society of the State of New York Mid-Winter Conference, Saratoga Springs, NY, Jan 2016.

Matthew Stryker
Part II: Starting Non-Insulin Medication in the Primary Care Setting for Type 2 Diabetes. American Diabetes Association – Innovations in Diabetes Care Annual Meeting, Troy, NY, November 10, 2016.

Alexandra Watson
Watson A. Comprehensive Primary Care (CPC) Leading Innovation, Inspiring Engagement. New York Region Full Day Learning Session, October 2016 (panelist).

Watson A. CapitalCare Medical Group Diabetes Support Group: Ask a Pharmacist. September 2016.

Watson A. Updates on Diabetes: A Focus on Guidelines and Pharmacotherapy. Continuing Education. ACPHS, Albany, NY, June 2016.

Watson A. Life on Rotations, APhA-ASP student chapter meeting, ACPHS, Albany, NY, May 2016.

Watson A. CapitalCare Medical Group Diabetes Support Group: Diabetes Medications and Neuropathy. January 2016.

Katie Cardone
Principal Investigator: Wendy M. Parker
Co-Principal Investigator: Katie E. Cardone
Project: Health disparities and medication management strategies among adolescents and young adults with Diabetes Mellitus
Grantor: John Faunce and Alicia Tracy Roach Fund
Amount: $24,943.36

Michael Kane, Matthew Stryker, Robert Hamilton
Project: A Real World, Observational Study of Weekly Exenatide Added to Basal Insulin in Patients with Type 2 Diabetes Mellitus
Grantor: AstraZeneca Pharmaceuticals, LP
Amount: $67,387
Awarded: July 2016

See-Won Seo, Jacqueline Cleary
Principal Investigator: See-Won Seo
Co-Principal Investigator: Jacqueline Cleary
Project: A System’s Approach to Reducing the Burden of Asthma in New York State
Grantor: Whitney M Young Jr. Health Center
Amount: $12,800
Awarded: June 2016

Thomas Lodise
Project: Antibacterial Resistance Leadership Group: Minocycline PK in IC Patients
Grantor: Duke University, National Institute of Allergy and Infectious Diseases (NIAID)
Amount: $35,802
Term: December 1, 2016 - November 30, 2017

Jeffrey Brewer
Fellow of the American Society of Health-System Pharmacists, 2016

Gina Garrison
National Secretary, Rho Chi Academic Honor Society, 2011-present

Jacqueline Cleary
2016 PAINWeek Scholarship Recipient

Nicole Lodise
American Association of Colleges of Pharmacy (AACP). Member, Tobacco Control Committee, Public Health Special Interest Group (2016- present).

American Association of Colleges of Pharmacy (AACP). Faculty Champion, Joint Council of Deans/Council of Faculties “Catalyst Team to Integrate the Joint Commission of Pharmacy Practitioners (JCPP) Pharmacists Patient Care Process (PPCP)” (2016-present).

American Association of Colleges of Pharmacy (AACP). Chair, Council of Faculties - Faculty Affairs Committee (COF-FAC) Workgroup on Curricular Adoption and Integration of the Pharmacists’ Patient Care Process (2015-2016).

American Association of Colleges of Pharmacy (AACP). Chair, Section of Teachers of Pharmacy Practice Faculty Development Committee (Chair- 2016-present).

American College of Clinical Pharmacy (ACCP). Member, Educational Affairs Committee (2016- present).

Nimish Patel
Society of Infectious Diseases Pharmacists: Impact Paper of the Year